HCW Biologics removes equity-plan proposal, reschedules special meeting
The company said it will remove Proposal No. 2, an amended performance-based equity plan, from its preliminary proxy. It also said it will reschedule the special meeting.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.